Free Trial
CVE:DBV

Doubleview Capital (DBV) Stock Price, News & Analysis

C$0.08 +0.01 (+7.14%)
As of 05/7/2020

About Doubleview Capital Stock (CVE:DBV)

Key Stats

Today's Range
C$0.07
C$0.08
50-Day Range
C$0.08
C$0.08
52-Week Range
C$0.04
C$0.14
Volume
86,000 shs
Average Volume
122,095 shs
Market Capitalization
C$8.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Doubleview Capital Corp. engages in the acquisition, exploration, and development of mineral resource properties in Canada. It explores for copper, gold, silver, and zinc deposits. The company holds interests in the Hat property with 10 mineral tenures totaling 6,308 hectares located in the northwestern British Columbia; and the Red Spring deposit situated to the north of Smithers, British Columbia. Doubleview Capital Corp. was incorporated in 2008 and is headquartered in Vancouver, Canada.

Receive DBV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doubleview Capital and its competitors with MarketBeat's FREE daily newsletter.

DBV Stock News Headlines

Kepler Capital Sticks to Their Buy Rating for DBV Technologies (0QAJ)
DBV Technologies (0QAJ) Receives a Buy from Kepler Capital
The Private Market Surge Is Coming in 2025
The most lucrative investment opportunities are reserved for a select category of investor. They're private. They're quiet. And they're often available exclusively to accredited investors operating outside the noise of the public markets. We're talking about off-market placements, early venture deals, private credit, and pre-IPO shares—the kind of plays that can generate outsized gains before Wall Street catches wind. Here's the reality: having access is only the beginning. These deals can be opaque, rushed, and filled with hidden risk. That's why we created something exclusively for investors like you—the 2025 Accredited Investor Playbook.
Kepler Capital Sticks to Its Buy Rating for DBV Technologies (0QAJ)
See More Headlines

DBV Stock Analysis - Frequently Asked Questions

Doubleview Capital's stock was trading at C$0.08 on January 1st, 2025. Since then, DBV stock has increased by 0.0% and is now trading at C$0.08.
View the best growth stocks for 2025 here
.

Shares of DBV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Doubleview Capital investors own include Tetra Bio-Pharma (TBPMF) and Cona Resources (CONA).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Industrial Metals & Minerals
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:DBV
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
17.50
Book Value
C$0.05 per share
Price / Book
1.53

Miscellaneous

Free Float
N/A
Market Cap
C$8.62 million
Optionable
Not Optionable
Beta
N/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (CVE:DBV) was last updated on 6/21/2025 by MarketBeat.com Staff
From Our Partners